11/08/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
9:52 AM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
4:07 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:05 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/01/2024
3:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:30 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
5:43 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
5:05 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:29 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:31 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:03 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:16 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:16 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:06 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:41 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:22 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:37 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:15 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:24 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:23 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:15 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:09 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/27/2024
5:48 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:20 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:20 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:21 PM | Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:21 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:22 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:23 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
10:28 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:47 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:37 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Wei Lin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:20 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:08 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:56 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:40 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:31 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
4:11 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form S-3ASR | |
05/03/2024
6:36 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:30 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEF 14A | |
04/25/2024
3:35 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
04/12/2024
7:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:23 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
3:57 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
3:24 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:43 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
03/20/2024
3:45 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:50 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:10 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:21 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:04 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:48 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:32 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free RVMD Stock Alerts